Practices


Lawyers Organizing for Mass Suits Over Vioxx

November 5, 2004 - Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the Read More


Liablity could Reach $17.6B

November 5, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects. Read More


Merck Faces Huge Fallout Over Vioxx Suits

November 4, 2004 - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects - lawsuits that... Read More


News that maker hid Vioxx data sinks stock 10 percent

November 2, 2004 - Shares of Merck & Co. plunged more than 10 percent yesterday after a news report said documents showed the pharmaceutical giant hid or denied evidence for years that its blockbuster... Read More


Senate investigators interview lawyer who has sued Merck

November 2, 2004 - Senate investigators examining Merck's recall of its Vioxx painkiller have interviewed an Alabama lawyer whose firm has filed 58 lawsuits against the company on Read More


Merck’s Woes Grow As Credit Rating is Put on Watch

November 2, 2004 - Amid growing concern about litigation over Vioxx, the painkiller yanked off the market, Merck & Co. shares fell nearly 10% and Standard & Poor's Rating Services placed the company's... Read More


Merck Stock Tumbles nearly 10 Percent

November 2, 2004 - Merck & Co.'s shares fell nearly 10 percent, to the lowest price in almost nine years, after The Wall Street Journal reported that the drug maker tried for years to stop safety concerns... Read More


Lawyers put pressure on Merck over Vioxx

November 2, 2004 - Plaintiffs' attorneys stepped up pressure on Merck on cases related to its withdrawal of Vioxx, the anti-inflammatory drug, sending the US drugmaker's shares plummeting again. Read More


Merck Falls on report of Secrecy

November 2, 2004 - Shares of Merck & Co. plunged again after a news report suggested the drug maker attempted to keep safety worries from hurting the prospects of Vioxx before the company finally recalled the... Read More


How bad will the lawsuits get, Really, Really Bad.

November 1, 2004 - Surveying the wreckage of the worst pharmaceutical tort litigations of the past, investors naturally want to know: Will Vioxx be the next Baycol, or Rezulin, or fen-phen? Our prediction is:... Read More


back to top